LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article: Teleradioterapia neoadjuwantowa zmniejsza stężenie prostaglandyny E2 w tkance nowotworowej i surowicy oraz ekspresję cyklooksygenazy-2 u chorych na raka odbytnicy.

    Mularczyk, Aldona / Gonciarz, Maciej

    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

    2016  Volume 41, Issue 242, Page(s) 70–73

    Abstract: Unlabelled: The carcinogenesis of colorectal cancer involves many factors, which modify the functioning of cells and can include prostaglandins. Resection of tumours and/or radiotherapy provide potentially curative therapy for cancer of the rectum.: ... ...

    Title translation Neoadiuvant teleradiotherapy decreases cancer tissue and serum concentration of prostaglandin E2 and cyclooxygenase-2 expression in patients with rectal cancer.
    Abstract Unlabelled: The carcinogenesis of colorectal cancer involves many factors, which modify the functioning of cells and can include prostaglandins. Resection of tumours and/or radiotherapy provide potentially curative therapy for cancer of the rectum.
    Aim: The aim of the study was to asses the effects of neoadiuvant teleradiotherapy on PGE2 concentrations in the serum and in the resected bowel tissue as well as on COX-2 gene expression in patients with rectal cancer.
    Materials and methods: Group I (n=20) included patients with resectable tumour (T1-2,No) treated exclusively by surgery, and group II (n=20) - patients with resectable tumours (T3) and nonresectable ones (T4). All the patients out of group II were put to the surgery after the previous teleradiotherapy applied to them. PGE2 concentrations were examined using the RIA method, while COX-2 mRNA expression was analyzed with the use of the PCR method.
    Results: PGE2 serum concentrations in the group I prior to the resection did not differ from PGE2 concentrations in the group II prior to the resection (p=0,9488). However, radiation had caused reduction of PGE2 serum concentration prior to the resection in patients from the group II in comparison with the group I (p=0,0115). PGE2 serum concentrations after resection in the group I did not differ significantly from PGE2 concentrations in group II after resection (p=0,4511) (two-factor analysis of variation with interaction, p=0,3117). Radiotherapy did not change significantly PGE2 concentrations in the tumour and margin (two-factor analysis of variations with interaction, p=0,3137). The comparison between the number of patients who showed higher COX-2 mRNA expression in tumour than in the margin in the group I and II, did not reveal differences (p=0,6614).
    Conclusions: Neoadiuvant teleradiotherapy decreased PGE2 concentration in the serum, thus showed similar effect as tumour resection.
    MeSH term(s) Cyclooxygenase 2/blood ; Dinoprostone/blood ; Humans ; Neoadjuvant Therapy ; Radiotherapy ; Rectal Neoplasms/blood ; Rectal Neoplasms/therapy
    Chemical Substances Cyclooxygenase 2 (EC 1.14.99.1) ; Dinoprostone (K7Q1JQR04M)
    Language Polish
    Publishing date 2016-08
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 1388406-2
    ISSN 1426-9686
    ISSN 1426-9686
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Mikroskopowe zapalenie jelita grubego – częsta przyczyna przewlekłej biegunki.

    Gonciarz, Maciej / Mularczyk, Aldona / Kowalik, Tomasz / Kopała, Marek

    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

    2016  Volume 41, Issue 245, Page(s) 248–250

    Abstract: Chronic diarrhea is a very common problem in the general population. It requires a physician to differentiate its causes and depending on its etiology referring the patient to a hospital for diagnosis and subsequent treatment. One of the causes of ... ...

    Title translation Microscopic colitis - a frequent cause of chronic diarrhea.
    Abstract Chronic diarrhea is a very common problem in the general population. It requires a physician to differentiate its causes and depending on its etiology referring the patient to a hospital for diagnosis and subsequent treatment. One of the causes of chronic diarrhea may be microscopic colitis, which is characterized by the presence of clinical symptoms without endoscopic or radiological abnormalities. Diagnosis is based on a histopathological examination of the colon and thus clinical suspicion of the disease is so important for further diagnosis and treatment, which is primarily based on the use of topical steroids such as budesonide.
    MeSH term(s) Anti-Inflammatory Agents/therapeutic use ; Budesonide/therapeutic use ; Chronic Disease ; Colitis, Microscopic/diagnosis ; Colitis, Microscopic/drug therapy ; Diarrhea/diagnosis ; Diarrhea/drug therapy ; Humans
    Chemical Substances Anti-Inflammatory Agents ; Budesonide (51333-22-3)
    Language Polish
    Publishing date 2016-11-25
    Publishing country Poland
    Document type Journal Article ; Review
    ZDB-ID 1388406-2
    ISSN 1426-9686
    ISSN 1426-9686
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Koncepcja hipotezy higienicznej w immunopatogenezie nieswoistych chorób zapalnych jelit.

    Gonciarz, Maciej / Szkudłapski, Dawid / Mularczyk, Aldona / Smagacz, Justyna

    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

    2016  Volume 40, Issue 240, Page(s) 384–387

    Abstract: Over three last decades, it has been noticed that morbidity of immunology-dependent illnesses, like asthma, inflammatory bowel disease or atopic dermatitis, apparently increased. That is the reason to focus on searching and exploring new ideas which ... ...

    Title translation Hygienic hypothesis in immunopathogenesis of inflammatory bowel disease.
    Abstract Over three last decades, it has been noticed that morbidity of immunology-dependent illnesses, like asthma, inflammatory bowel disease or atopic dermatitis, apparently increased. That is the reason to focus on searching and exploring new ideas which could explain etiopathology of those diseases. In etiopathology the role of environmental factors is particularly emphasized. Research indicated the inverse relationship between the frequency of infectious and/ or parasites and autoimmune diseases. It was a leading subject of many studies what allowed to create a hypothesis which explains the phenomenon. The most original and innovative idea, named hygenic hypothesis, was proposed in the late 80s of the last century. Avoiding or limiting the contact with common bacteria and parasites in well-and very well-developed countries probably caused depletion of immune memory which resulted in the hypersensitive response after exposure to general factors. Nowadays, autoimmunological diseases make really serious problem for medical care in the United States of America and Western European countries, ranking just behind cardiovascular diseases, cancer and metabolic sicknesses.
    MeSH term(s) Humans ; Hygiene ; Immune System ; Inflammatory Bowel Diseases/etiology ; Inflammatory Bowel Diseases/immunology ; Inflammatory Bowel Diseases/microbiology ; Inflammatory Bowel Diseases/parasitology
    Language Polish
    Publishing date 2016-06
    Publishing country Poland
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 1388406-2
    ISSN 1426-9686
    ISSN 1426-9686
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: A case of melatonin-induced biochemical flare in a patient with primary sclerosing cholangitis with features of autoimmune hepatitis.

    Gonciarz, Maciej / Mularczyk, Aldona / Szkudłapski, Dawid / Konturek, Stanislaw J / Konturek, Peter C

    Przeglad gastroenterologiczny

    2019  Volume 14, Issue 2, Page(s) 157–159

    Language English
    Publishing date 2019-07-05
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 2596134-2
    ISSN 1897-4317 ; 1895-5770
    ISSN (online) 1897-4317
    ISSN 1895-5770
    DOI 10.5114/pg.2019.85901
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Adalimumab w indukcji remisji w chorobie Leśniowskiego- Crohna – studium jednoośrodkowe.

    Gonciarz, Maciej / Mularczyk, Aldona / Szkudłapski, Dawid / Piątek, Iwona / Kopała, Marek

    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

    2016  Volume 41, Issue 245, Page(s) 216–220

    Abstract: Adalimumab is a subcutaneously administered recombinant fully human monoclonal antibody targeting tumor necrosis factor alpha. It has been approved for use in Poland to treat patients with Crohn's disease under the program of Polish National Health Found ...

    Title translation Adalimumab as induction therapy for Crohn's disease - one center study.
    Abstract Adalimumab is a subcutaneously administered recombinant fully human monoclonal antibody targeting tumor necrosis factor alpha. It has been approved for use in Poland to treat patients with Crohn's disease under the program of Polish National Health Found since 2010.
    Aim: The aim of this study was to evaluate the efficacy of adalimumab monotherapy for inducing clinical remission in patients with active Crohn's disease . The primary outcome assessment was the reduction in score to 150 or below on the Crohn's Disease Activity Index (CDAI) at 12 weeks and the secondary one was the reduction in ΔCDAI of at least 100 points.
    Materials and methods: From January 2011 to December 2015 we treated 68 patients with active Crohn's disease (mean CDAI score 359). All the patients came from region of Silesia, an area with the same environment conditions. The patients were given adalimumab (Humira, AbbVie) subcutaneously at a dose of 160 mg at week 0, 80 mg at week 4 and 40 mg every two weeks thereafter.
    Results: Twenty eight patients (41%) had a clinical remission at week 12 (CDAI ≤150) and 33 patients (49%) had a ΔCDAI response. During the 12-week of induction therapy infection with Clostridium difficile occurred in 4 patients and one patient died of a severe CMV infection.
    Conclusions: Adalimumab is effective as induction therapy for patients with moderate-to-severe Crohn's disease, however in individual cases serious infections including CMV infection can occur. A potential predictive factors for response can be female gender, non-smoking status and high CRP level at baseline.
    MeSH term(s) Adalimumab/administration & dosage ; Adolescent ; Adult ; Antibodies, Monoclonal/administration & dosage ; Crohn Disease/drug therapy ; Female ; Humans ; Injections, Subcutaneous ; Male ; Middle Aged ; Poland ; Remission Induction ; Treatment Outcome ; Young Adult
    Chemical Substances Antibodies, Monoclonal ; Adalimumab (FYS6T7F842)
    Language Polish
    Publishing date 2016-11-25
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 1388406-2
    ISSN 1426-9686
    ISSN 1426-9686
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Biosimilar medicines - their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology.

    Mularczyk, Aldona / Gonciarz, Maciej / Bartnik, Witold / Durlik, Marek / Eder, Piotr / Gąsiorowska, Anita / Linke, Krzysztof / Lodyga, Michał / Lykowska-Szuber, Liliana / Małecka-Panas, Ewa / Pawlik, Magdalena / Radwan, Piotr / Rydzewska, Grażyna

    Przeglad gastroenterologiczny

    2014  Volume 9, Issue 1, Page(s) 1–3

    Abstract: Biological medical products are drugs whose active components are produced only by living, genetically modified organisms or live cell cultures. Patents and exclusivity for most biopharmaceuticals has either expired or will expire soon, which enables ... ...

    Abstract Biological medical products are drugs whose active components are produced only by living, genetically modified organisms or live cell cultures. Patents and exclusivity for most biopharmaceuticals has either expired or will expire soon, which enables biotechnological companies to introduce similar biological products. The problem of replacing a biological medicine with a biosimilar in the course of therapy remains open. In this statement, the Working Group of the Polish National Consultant in Gastroenterology, in the absence of data regarding bioequivalence in patients with inflammatory bowel disease, does not recommend switching from original biological medicine to its biosimilar analogue in the course of treatment in inflammatory disease patients; however, this may change after receiving the results of controlled studies regarding bioequivalence in this group.
    Language English
    Publishing date 2014-03-01
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 2596134-2
    ISSN 1897-4317 ; 1895-5770
    ISSN (online) 1897-4317
    ISSN 1895-5770
    DOI 10.5114/pg.2014.40842
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Conscious analgesia/sedation with remifentanil and propofol versus total intravenous anesthesia with fentanyl, midazolam, and propofol for outpatient colonoscopy.

    Rudner, Robert / Jalowiecki, Przemyslaw / Kawecki, Piotr / Gonciarz, Maciej / Mularczyk, Aldona / Petelenz, Michal

    Gastrointestinal endoscopy

    2003  Volume 57, Issue 6, Page(s) 657–663

    Abstract: Background: This study tested the hypothesis that, for colonoscopy, analgesia/sedation with remifentanil and propofol might be more effective compared with anesthesia by intravenous administration of midazolam, fentanyl, and propofol.: Methods: In a ... ...

    Abstract Background: This study tested the hypothesis that, for colonoscopy, analgesia/sedation with remifentanil and propofol might be more effective compared with anesthesia by intravenous administration of midazolam, fentanyl, and propofol.
    Methods: In a prospective, randomized trial, 100 adult patients received either conscious analgesia/sedation (Sedation group) or total intravenous anesthesia (TIVA group). Analgesia/sedation was achieved by infusion of remifentanil (0.20 to 0.25 microg/kg/min) and propofol in titrated doses. TIVA was induced by intravenous administration of fentanyl (2 microg/kg), midazolam (0.05 mg/kg) and propofol (dosage titrated). Cardiorespiratory parameters and bispectral index were monitored and recorded. The quality of the analgesia was assessed with a Numerical Pain Rating Scale (NRS); recovery level and return of psychomotor efficiency were evaluated with, respectively, the Aldrete scale and a Modified Post Anesthesia Discharge Scoring (MPADS) system.
    Results: Both groups of 50 patients were comparable with respect to demographic data, initial parameters, and duration of colonoscopy. All patients in the TIVA group found the colonoscopy painless (NRS score 0). In the Sedation group, the average pain intensity score was 0.4 (0.8). There was a marked difference between the Sedation and TIVA groups with respect to the time from the end of the procedure until the maximum MPADS score was reached: respectively, -6.9 (4.0) versus 25.7 (8.4) minutes (p < 0.001). In the TIVA group, changes in mean arterial pressure and heart rate and signs of respiratory depression were significant (p < 0.05).
    Conclusions: Combined administration of remifentanil and propofol for colonoscopy provides sufficient analgesia, satisfactory hemodynamic stability, minor respiratory depression, and rapid recovery, and allows patients to be discharged approximately 15 minutes after the procedure.
    MeSH term(s) Adolescent ; Adult ; Aged ; Ambulatory Surgical Procedures ; Anesthesia, General ; Colonoscopy ; Conscious Sedation ; Female ; Fentanyl/pharmacology ; Humans ; Hypnotics and Sedatives/administration & dosage ; Hypnotics and Sedatives/pharmacology ; Male ; Midazolam/pharmacology ; Middle Aged ; Pain Measurement ; Piperidines/pharmacology ; Propofol/administration & dosage ; Propofol/pharmacology
    Chemical Substances Hypnotics and Sedatives ; Piperidines ; remifentanil (P10582JYYK) ; Midazolam (R60L0SM5BC) ; Fentanyl (UF599785JZ) ; Propofol (YI7VU623SF)
    Language English
    Publishing date 2003-05
    Publishing country United States
    Document type Clinical Trial ; Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 391583-9
    ISSN 1097-6779 ; 0016-5107
    ISSN (online) 1097-6779
    ISSN 0016-5107
    DOI 10.1067/mge.2003.207
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top